Johnson & Johnson (JNJ) Intangibles (2009 - 2026)
Johnson & Johnson's Intangibles was $46.65 billion in Q3 2026, down 4.3% from $48.74 billion a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at Johnson & Johnson came in at $50.4 billion, up 34.0% from FY2024.
- Intangibles shows a four-year compound annual growth rate of -1.4% (FY2021 to FY2025).
- In earlier years, Intangibles was $37.62 billion in FY2024 (+10.1%), $34.18 billion in FY2023 (-11.2%), $38.49 billion in FY2022 and $53.4 billion in FY2021.
- The Q3 2026 figure marks the lowest quarterly Intangibles since Q1 2025.
- Compared with a year earlier, Intangibles was higher in six of the last eight quarters, with growth averaging 15.8%.
- The best year-over-year quarter for Intangibles over five years was Q4 2025 (growth of 34.0%); the worst was Q1 2024 (a decline of 27.7%).
- Per Business Quant data, JNJ's Intangibles in the three quarters before Q3 2026 was $48.23 billion (Q2 2026), $49.06 billion (Q1 2026) and $50.4 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,263.50 Bn | 1,237.12 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 655.05 Bn | 574.91 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 512.00 Bn | 485.11 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 368.57 Bn | 368.57 Bn | - | - |
| 5 | Novartis Ag | 313.61 Bn | 286.85 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 290.22 Bn | 263.91 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 252.64 Bn | 208.04 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 212.62 Bn | 212.62 Bn | - | 13.42 Bn |
| 9 | Pfizer | 175.96 Bn | 122.60 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Vertex Pharmaceuticals | 140.19 Bn | 112.20 Bn | 2.84 Bn | 412.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 46.65 Bn |
| Jun 28, 2026 | 48.23 Bn |
| Mar 29, 2026 | 49.06 Bn |
| Dec 28, 2025 | 50.40 Bn |
| Sep 28, 2025 | 48.74 Bn |
| Jun 29, 2025 | 49.84 Bn |
| Mar 30, 2025 | 36.76 Bn |
| Dec 29, 2024 | 37.62 Bn |
| Sep 29, 2024 | 39.49 Bn |
| Jun 30, 2024 | 39.73 Bn |
| Mar 31, 2024 | 34.29 Bn |
| Dec 31, 2023 | 34.18 Bn |
| Oct 1, 2023 | 35.02 Bn |
| Jul 2, 2023 | 46.25 Bn |
| Apr 2, 2023 | 47.45 Bn |
| Jan 1, 2023 | 38.49 Bn |
| Oct 2, 2022 | 40.34 Bn |
| Jul 3, 2022 | 42.41 Bn |
| Apr 3, 2022 | 44.42 Bn |
| Jan 2, 2022 | 46.39 Bn |
API Access
Johnson & Johnson Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();